SCHEMBL26320536

SCHEMBL26320536

Cc1ccc(C(=O)CS(=O)(=O)c2nc3ccccc3s2)cc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 3/20 0.47
ALPG P10696 3/20 0.47
GCGR P47871 1/20 0.47
HSD17B1 P14061 2/20 0.46
HSD17B2 P37059 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2B6 P20813 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 5/20 0.46
MAPT P10636 5/20 0.46
KMT2A Q03164 4/20 0.46
LMNA P02545 3/20 0.46
HTT P42858 3/20 0.46
MEN1 O00255 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23196653 0.90 ALPL (0.59) ALPLALPGGCGRHSD17B1HSD17B2
SCHEMBL26320533 0.78 MAPT (0.43) ALDH1A1MAPTKMT2AHTTMEN1
SCHEMBL26320568 0.76 ALPL (0.80) ALPLALPGGCGRCYP1A2CYP3A4
SCHEMBL16625012 0.75 ALDH1A1 (0.60) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL26320537 0.74 ALPL (0.47) ALPLALPGGCGRHSD17B1HSD17B2
SCHEMBL3595617 0.71 ALDH1A1 (0.67) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL30149949 0.71 ALDH1A1 (0.67) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL7905772 0.70 ALDH1A1 (0.65) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL26320526 0.70 ALDH1A1 (0.43) ALPLALPGHSD17B1HSD17B2CYP1A2
SCHEMBL9636277 0.67 ALDH1A1 (0.65) CYP1A2CYP2D6ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230293499-A1 COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO US GOV VETERANS AFFAIRS (US) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230293499-A1 COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO NFKBIA, NCBP1, NFKB1 ALPL 4374/4885ALPG 4545/4885GCGR 4625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.